Relay Therapeutics stockRLAY
Relay Therapeutics trades at $17.00, 20.1% below its 52-week high (Aug 19, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +100.9% year to date, +159.5% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 25, 2027.
Ratings, candles, signals and the screener for RLAY — after you log in
Open the terminalFrequently asked questions about Relay Therapeutics
What is the Relay Therapeutics stock price?
At the close on Nov 5, 2026: $17.00 (−5.71% on the day). 52-week high: $21.27 on Aug 19, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Relay Therapeutics report earnings?
The next quarterly report is on Feb 25, 2027. Last quarter, earnings per share changed +14% year over year, revenue −50%.
Does Relay Therapeutics pay dividends?
No, Relay Therapeutics does not pay dividends.
Where does Relay Therapeutics trade and how to buy it?
Ticker RLAY, exchange Nasdaq, listed since 2020. You can buy it through a broker with access to US exchanges.
Should I buy Relay Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for RLAY are in the terminal after you log in.